Liposomal irinotecan, oxaliplatin, and S-1 as first-line therapy for patients with locally advanced or metastatic pancreatic adenocarcinoma (NASOX): A multicenter phase I/IIa study
Titel:
Liposomal irinotecan, oxaliplatin, and S-1 as first-line therapy for patients with locally advanced or metastatic pancreatic adenocarcinoma (NASOX): A multicenter phase I/IIa study
Auteur:
Jeong, Hyehyun Kim, Bum Jun Lee, Choong-kun Park, Inkeun Zang, Dae Young Choi, Hye Jin Lee, Sang Soo Park, Do Hyun Song, Tae Jun Oh, Dongwook Moon, Sung-Hoon Kim, Kyu-pyo Wainberg, Zev Ryoo, Baek-Yeol Yoo, Changhoon